MMED
MiniMed Group, Inc.
Price Chart
Latest Quote
$14.13
+0.39 (+2.84%)
Current Price
| Previous Close | $13.74 |
| Open | $13.97 |
| Day High | $14.98 |
| Day Low | $13.95 |
| Volume | 1,085,139 |
Stock Information
| Shares Outstanding | 280.82M |
| Total Debt | $61.00M |
| Cash Equivalents | $10.00M |
| Revenue | $3.10B |
| Net Income | $-331.00M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $3.97B |
| EPS (TTM) | $-1.27 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $3.91B |
| Sales | $3.10B |
| Income | $-331.00M |
| Book/sh | $12.33 |
| Cash/sh | $0.04 |
Financial Ratios
| Debt/Eq | 1.76 |
Returns & Margins
| ROE | -9.28% |
| Gross Margin | 54.16% |
| Operating Margin | -10.27% |
| Profit Margin | -10.67% |
Ownership
| Insider Ownership | 90.51% |
| Institutional Ownership | 11.60% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 20.74 |
| P/S | 1.28 |
| P/B | 1.15 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $20.91 |
Technical Indicators
| SMA20 | $13.86 |
| SMA50 | $12.97 |
| RSI | 48.87 |
| ATR | 0.8979 |
| Shares Float | 28.00M |
| Short Float | 14.43% |
| Short Ratio | 6.39 |
| Rel Volume | 1.07 |
Performance History
| Week | -3.88% |
| Month | +19.04% |
| Quarter | -13.37% |
| YTD | -23.58% |
| 10 Years | -23.58% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $14.13 | 1,103,085 |
| 2026-06-23 | $13.74 | 537,600 |
| 2026-06-22 | $14.22 | 631,500 |
| 2026-06-18 | $14.77 | 2,855,000 |
| 2026-06-17 | $14.17 | 561,400 |
| 2026-06-16 | $14.70 | 460,500 |
| 2026-06-15 | $15.00 | 1,020,000 |
| 2026-06-12 | $15.16 | 963,100 |
| 2026-06-11 | $15.47 | 1,413,700 |
| 2026-06-10 | $14.71 | 748,600 |
| 2026-06-09 | $15.12 | 798,900 |
| 2026-06-08 | $14.88 | 742,200 |
| 2026-06-05 | $14.23 | 457,600 |
| 2026-06-04 | $14.06 | 1,263,000 |
| 2026-06-03 | $14.26 | 2,965,600 |
| 2026-06-02 | $12.30 | 1,062,600 |
| 2026-06-01 | $12.00 | 1,086,600 |
| 2026-05-29 | $12.04 | 574,100 |
| 2026-05-28 | $11.51 | 569,900 |
| 2026-05-27 | $10.80 | 730,700 |
| 2026-05-26 | $11.18 | 516,200 |
About MiniMed Group, Inc.
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, including insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera, or Guardian 4, and wraparound applications and services. MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California.
đ° Latest News
This Undervalued Medical-Devices Stock Is Poised for a Rebound
Barrons.com âĸ 2026-06-22T15:45:00Z
A Look At MiniMed Group (MMED) Valuation After Recent Share Price Volatility
Simply Wall St. âĸ 2026-06-09T00:17:27Z
Medtronic Bottoms, Healthy Rebound Ahead
MarketBeat âĸ 2026-06-04T17:10:00Z
Minimed Group Inc (MMED) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Product ...
GuruFocus.com âĸ 2026-06-03T21:00:32ZMedtronic Stock Is Defying a Market Selloff After Earnings. Hereâs Why.
Barrons.com âĸ 2026-06-03T20:45:00Z
MiniMed Group Q4 Earnings Call Highlights
MarketBeat âĸ 2026-06-03T14:08:48Z
MMED's Latest Study Supports the Strength of 780G SmartGuard Algorithm
Zacks âĸ 2026-05-22T14:33:00Z
Toast downgraded, Lowe's upgraded: Wall Street's top analyst calls
The Fly âĸ 2026-05-12T13:56:25Z
Here Are Tuesdayâs Top Wall Street Analyst Research Calls: Autodesk, Celanese, DexCom, FormFactor, GitLab, Loweâs, Matador Resources, Toast and More
24/7 Wall St. âĸ 2026-05-12T11:54:21Z
Is It Time To Reassess MiniMed Group (MMED) After This Yearâs Sharp Share Price Fall
Simply Wall St. âĸ 2026-05-11T11:10:26Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-04-30 | 2024-04-30 | 2023-04-30 |
|---|---|---|---|
| Revenue | |||
| Reconciled Cost Of Revenue | $1,190,000,000 | $1,032,000,000 | $937,000,000 |
| Cost Of Revenue | $1,190,000,000 | $1,032,000,000 | $937,000,000 |
| Total Revenue | $2,715,000,000 | $2,469,000,000 | $2,245,000,000 |
| Operating Revenue | $2,715,000,000 | $2,469,000,000 | $2,245,000,000 |
| Expenses | |||
| Total Expenses | $2,751,000,000 | $2,537,000,000 | $2,314,000,000 |
| Other Income Expense | $-166,000,000 | $-1,000,000 | $-7,000,000 |
| Other Non Operating Income Expenses | $-1,000,000 | $-1,000,000 | $-7,000,000 |
| Operating Expense | $1,561,000,000 | $1,505,000,000 | $1,377,000,000 |
| Other Operating Expenses | $-8,000,000 | $11,000,000 | $-12,000,000 |
| Selling And Marketing Expense | $1,131,000,000 | $1,057,000,000 | $960,000,000 |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $-250,000,000 | $-112,000,000 | $-96,000,000 |
| Normalized Income | $-119,650,000 | $-112,000,000 | $-96,000,000 |
| Net Income From Continuing And Discontinued Operation | $-250,000,000 | $-112,000,000 | $-96,000,000 |
| Total Operating Income As Reported | $-202,000,000 | $-69,000,000 | $-69,000,000 |
| Net Income Common Stockholders | $-250,000,000 | $-112,000,000 | $-96,000,000 |
| Net Income | $-250,000,000 | $-112,000,000 | $-96,000,000 |
| Net Income Including Noncontrolling Interests | $-250,000,000 | $-107,000,000 | $-92,000,000 |
| Net Income Continuous Operations | $-251,000,000 | $-108,000,000 | $-92,000,000 |
| Pretax Income | $-203,000,000 | $-70,000,000 | $-76,000,000 |
| Special Income Charges | $-165,000,000 | $0 | $0 |
| Operating Income | $-36,000,000 | $-69,000,000 | $-69,000,000 |
| Gross Profit | $1,525,000,000 | $1,436,000,000 | $1,308,000,000 |
| Per Share | |||
| Diluted EPS | $-0.89 | $-0.40 | $-0.34 |
| Basic EPS | $-0.89 | $-0.40 | $-0.34 |
| Other | |||
| Tax Effect Of Unusual Items | $-34,650,000 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $272,000,000 | $60,000,000 | $46,000,000 |
| Total Unusual Items | $-165,000,000 | $0 | $0 |
| Total Unusual Items Excluding Goodwill | $-165,000,000 | $0 | $0 |
| Reconciled Depreciation | $143,000,000 | $129,000,000 | $115,000,000 |
| EBITDA (Bullshit earnings) | $107,000,000 | $60,000,000 | $46,000,000 |
| EBIT | $-36,000,000 | $-69,000,000 | $-69,000,000 |
| Diluted Average Shares | $280,813,348 | $280,813,348 | $280,813,348 |
| Basic Average Shares | $280,813,348 | $280,813,348 | $280,813,348 |
| Diluted NI Availto Com Stockholders | $-250,000,000 | $-112,000,000 | $-96,000,000 |
| Minority Interests | $0 | $-5,000,000 | $-5,000,000 |
| Tax Provision | $48,000,000 | $38,000,000 | $16,000,000 |
| Other Special Charges | $165,000,000 | - | - |
| Research And Development | $438,000,000 | $437,000,000 | $429,000,000 |
| Selling General And Administration | $1,131,000,000 | $1,057,000,000 | $960,000,000 |
Fetched: 2026-06-22
Balance Sheet (Annual)
| Metric | 2025-04-30 | 2024-04-30 |
|---|---|---|
| Assets | ||
| Net Tangible Assets | $945,000,000 | $1,033,000,000 |
| Total Assets | $4,201,000,000 | $4,094,000,000 |
| Total Non Current Assets | $3,261,000,000 | $3,198,000,000 |
| Other Non Current Assets | $150,000,000 | $131,000,000 |
| Non Current Accounts Receivable | $19,000,000 | $16,000,000 |
| Goodwill And Other Intangible Assets | $2,386,000,000 | $2,415,000,000 |
| Other Intangible Assets | $131,000,000 | $160,000,000 |
| Current Assets | $939,000,000 | $895,000,000 |
| Other Current Assets | $48,000,000 | $42,000,000 |
| Inventory | $310,000,000 | $292,000,000 |
| Receivables | $570,000,000 | $507,000,000 |
| Accounts Receivable | $570,000,000 | $507,000,000 |
| Allowance For Doubtful Accounts Receivable | $-46,000,000 | $-40,000,000 |
| Gross Accounts Receivable | $616,000,000 | $547,000,000 |
| Cash Cash Equivalents And Short Term Investments | $11,000,000 | $54,000,000 |
| Cash And Cash Equivalents | $11,000,000 | $54,000,000 |
| Debt | ||
| Total Debt | $11,000,000 | $8,000,000 |
| Current Debt And Capital Lease Obligation | $11,000,000 | $8,000,000 |
| Liabilities | ||
| Total Liabilities Net Minority Interest | $870,000,000 | $646,000,000 |
| Total Non Current Liabilities Net Minority Interest | $160,000,000 | $128,000,000 |
| Other Non Current Liabilities | $160,000,000 | $128,000,000 |
| Current Liabilities | $710,000,000 | $518,000,000 |
| Other Current Liabilities | $1,000,000 | $-1,000,000 |
| Current Deferred Liabilities | $11,000,000 | $11,000,000 |
| Payables And Accrued Expenses | $505,000,000 | $331,000,000 |
| Payables | $205,000,000 | $190,000,000 |
| Accounts Payable | $205,000,000 | $190,000,000 |
| Equity | ||
| Common Stock Equity | $3,331,000,000 | $3,448,000,000 |
| Total Equity Gross Minority Interest | $3,331,000,000 | $3,448,000,000 |
| Stockholders Equity | $3,331,000,000 | $3,448,000,000 |
| Other Equity Interest | $3,328,000,000 | $3,464,000,000 |
| Gains Losses Not Affecting Retained Earnings | $3,000,000 | $-16,000,000 |
| Other Equity Adjustments | $3,000,000 | $-16,000,000 |
| Other | ||
| Ordinary Shares Number | $280,813,348 | $280,813,348 |
| Share Issued | $280,813,348 | $280,813,348 |
| Tangible Book Value | $945,000,000 | $1,033,000,000 |
| Invested Capital | $3,331,000,000 | $3,448,000,000 |
| Working Capital | $229,000,000 | $377,000,000 |
| Capital Lease Obligations | $11,000,000 | $8,000,000 |
| Total Capitalization | $3,331,000,000 | $3,448,000,000 |
| Current Deferred Revenue | $11,000,000 | $11,000,000 |
| Current Capital Lease Obligation | $11,000,000 | $8,000,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $182,000,000 | $169,000,000 |
| Current Accrued Expenses | $300,000,000 | $141,000,000 |
| Goodwill | $2,255,000,000 | $2,255,000,000 |
| Net PPE | $706,000,000 | $636,000,000 |
| Accumulated Depreciation | $-663,000,000 | $-556,000,000 |
| Gross PPE | $1,369,000,000 | $1,192,000,000 |
| Construction In Progress | $286,000,000 | $294,000,000 |
| Other Properties | $396,000,000 | $343,000,000 |
| Machinery Furniture Equipment | $447,000,000 | $334,000,000 |
| Buildings And Improvements | $233,000,000 | $214,000,000 |
| Land And Improvements | $7,000,000 | $7,000,000 |
| Properties | $0 | $0 |
| Finished Goods | $185,000,000 | $165,000,000 |
| Work In Process | $38,000,000 | $28,000,000 |
| Raw Materials | $87,000,000 | $99,000,000 |
Fetched: 2026-06-22
Cash Flow Statement (Annual)
| Metric | 2025-04-30 | 2024-04-30 | 2023-04-30 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $-53,000,000 | $-107,000,000 | $-173,000,000 |
| Operating Activities | |||
| Operating Cash Flow | $140,000,000 | $41,000,000 | $-6,000,000 |
| Cash Flow From Continuing Operating Activities | $140,000,000 | $40,000,000 | $-4,000,000 |
| Operating Gains Losses | $8,000,000 | $8,000,000 | $10,000,000 |
| Investing Activities | |||
| Capital Expenditure | $-193,000,000 | $-148,000,000 | $-167,000,000 |
| Investing Cash Flow | $-193,000,000 | $-157,000,000 | $-180,000,000 |
| Cash Flow From Continuing Investing Activities | $-193,000,000 | $-156,000,000 | $-180,000,000 |
| Net Other Investing Changes | - | $-15,000,000 | - |
| Financing Activities | |||
| Financing Cash Flow | $10,000,000 | $112,000,000 | $185,000,000 |
| Cash Flow From Continuing Financing Activities | $10,000,000 | $112,000,000 | $185,000,000 |
| Net Other Financing Charges | $10,000,000 | $112,000,000 | $185,000,000 |
| Other | |||
| End Cash Position | $11,000,000 | $54,000,000 | $58,000,000 |
| Beginning Cash Position | $54,000,000 | $58,000,000 | $60,000,000 |
| Changes In Cash | $-43,000,000 | $-4,000,000 | $-2,000,000 |
| Net Investment Purchase And Sale | $0 | $6,000,000 | $-13,000,000 |
| Sale Of Investment | $0 | $11,000,000 | $0 |
| Purchase Of Investment | $0 | $-5,000,000 | $-13,000,000 |
| Net PPE Purchase And Sale | $-193,000,000 | $-148,000,000 | $-167,000,000 |
| Purchase Of PPE | $-193,000,000 | $-148,000,000 | $-167,000,000 |
| Change In Working Capital | $122,000,000 | $-74,000,000 | $-90,000,000 |
| Change In Other Working Capital | $16,000,000 | $30,000,000 | $-6,000,000 |
| Change In Payables And Accrued Expense | $191,000,000 | $-4,000,000 | $14,000,000 |
| Change In Payable | $191,000,000 | $-4,000,000 | $14,000,000 |
| Change In Account Payable | $191,000,000 | $-4,000,000 | $14,000,000 |
| Change In Inventory | $-19,000,000 | $5,000,000 | $-28,000,000 |
| Change In Receivables | $-66,000,000 | $-105,000,000 | $-70,000,000 |
| Changes In Account Receivables | $-66,000,000 | $-105,000,000 | $-70,000,000 |
| Other Non Cash Items | $5,000,000 | $22,000,000 | $12,000,000 |
| Stock Based Compensation | $41,000,000 | $38,000,000 | $35,000,000 |
| Provisionand Write Offof Assets | $21,000,000 | $22,000,000 | $15,000,000 |
| Deferred Tax | $-2,000,000 | $3,000,000 | $-11,000,000 |
| Deferred Income Tax | $-2,000,000 | $3,000,000 | $-11,000,000 |
| Depreciation Amortization Depletion | $143,000,000 | $129,000,000 | $115,000,000 |
| Depreciation And Amortization | $143,000,000 | $129,000,000 | $115,000,000 |
| Amortization Cash Flow | $29,000,000 | $33,000,000 | $33,000,000 |
| Amortization Of Intangibles | $29,000,000 | $33,000,000 | $33,000,000 |
| Depreciation | $114,000,000 | $96,000,000 | $82,000,000 |
| Pension And Employee Benefit Expense | $8,000,000 | $8,000,000 | $10,000,000 |
| Net Income From Continuing Operations | $-198,000,000 | $-107,000,000 | $-92,000,000 |
Fetched: 2026-06-22